NUCALA® Mepolizumab Injection Single Dose Vial

McKesson #	1184533
Manufacturer #	00173088101
Brand	NUCALA®
Manufacturer	Glaxo Specialty
Country of Origin	Unknown
Application	Interleukin-5 (IL-5)
Container Type	Single Dose Vial
Dosage Form	Injection
Generic Drug Name	Mepolizumab
NDC Number	00173-0881-01
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements	USP Controlled Room Temperature
Type	Subcutaneous
UNSPSC Code	51202400

NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: Add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype.
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for ≥6 months without an identifiable non hematologic secondary cause.
Requires Refrigeration